IBIS World valued the British Telehealth Services industry at GBP 585.6 million in 2022, growing at an annual rate of 19.8% since 2017[ix], while the UK’s telemedicine market was valued at just over GBP 1.2 billion in 2022, forecast to reach GBP 12.7 billion by 2030[x].

It would be wise for investors to enter this ESG-friendly market early, as it is clearly experiencing rapid growth, especially in the UK. Demand is driven hugely in the UK.

From the British Medical Association, the average daily number of hospital beds has been slightly decreasing since 2010, with constant demand. The UK has significantly fewer hospital beds relative to comparable nations, estimated at around 2.4 beds per 1,000 habitants[xi]; telemedicine and telehealth services can reduce this downward pressure on the NHS through the use of devices such as home-based and wearable monitoring equipment, alongside many other ‘virtual’ medicinal services.

Clearly, the British Telehealth and Telemedicine Companies are poised for great expansion and growth. JCinus Partners introduce an array of potential investment opportunities within this sector, mostly London-based seed businesses. Please see below:

Company B

We first introduce Company B as one of promising telemedicine companies, a seed company focused on providing holistic care, telehealth and wellness treatments for those with cancer. The business offers quick, online advice from NHS-qualified professionals at affordable pricing rates, alongside more than 20 holistic cancer support treatments. Since its inception in 2020, Perci Health has received GBP 4.9 million in funding from just one investor.

Company D

Company D, as one of growth telemedicine companies, is a series A company providing an app-based client engagement platform for veterinarians, supporting them in engaging better with pet owners. The app’s features comprise of a role-based text chat, including the potential to access the capabilities of the entire vet team, video consultations and payment processing services. Founded in 2019, the business has already generated USD 17 million in three rounds of funding.

Company F

This next business is a global leader in remote patient engagement solutions, offering clinical exercise prescriptions, patient education, results analysis and many other telehealth services. Founded in 2012, the company already has a global presence, with offices in the Netherlands, Australia, UK and the US. Company F has achieved USD 3.5 million in funding across three rounds. It is expected to be one of global telemedicine companies.

Company R

This seed company based in Solihull, Birmingham, operates as a telemedicine platform, connecting patients in the Middle East & Africa with international medical professionals via video chat. Patients are granted highly detailed medical reports post-video consultation from up to four different specialists, with an option to travel abroad to consult with the experts or to receive treatment. This young startup has gained GBP 300,000 over two rounds of funding.

Company Y

Finally, we present an AI-driven telemedicine platform. The integrated base offers medical services, virtual consultations and AI-powered symptom checkers for efficient, cost-effective patient care. Company Y also strives promote a general healthier culture by engaging with communities and prioritising lifestyle and physical fitness. Founded in 2022, the startup hosted their first round of funding in April 2023.